These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26366971)

  • 1. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.
    Simon DK; Wu C; Tilley BC; Wills AM; Aminoff MJ; Bainbridge J; Hauser RA; Schneider JS; Sharma S; Singer C; Tanner CM; Truong D; Wong PS
    Clin Neuropharmacol; 2015; 38(5):163-9. PubMed ID: 26366971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine, creatine, GRIN2A and Parkinson's disease progression.
    Simon DK; Wu C; Tilley BC; Lohmann K; Klein C; Payami H; Wills AM; Aminoff MJ; Bainbridge J; Dewey R; Hauser RA; Schaake S; Schneider JS; Sharma S; Singer C; Tanner CM; Truong D; Wei P; Wong PS; Yang T
    J Neurol Sci; 2017 Apr; 375():355-359. PubMed ID: 28320167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine and progression of Parkinson disease.
    Simon DK; Swearingen CJ; Hauser RA; Trugman JM; Aminoff MJ; Singer C; Truong D; Tilley BC;
    Clin Neuropharmacol; 2008; 31(4):189-96. PubMed ID: 18670242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
    Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
    Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
    NINDS NET-PD Investigators
    Neurology; 2006 Mar; 66(5):664-71. PubMed ID: 16481597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.
    NINDS NET-PD Investigators
    Clin Neuropharmacol; 2008; 31(3):141-50. PubMed ID: 18520981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's Disease.
    Kumar PM; Paing SS; Li H; Pavanni R; Yuen Y; Zhao Y; Tan EK
    Sci Rep; 2015 Nov; 5():15492. PubMed ID: 26522888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
    Bender A; Koch W; Elstner M; Schombacher Y; Bender J; Moeschl M; Gekeler F; Müller-Myhsok B; Gasser T; Tatsch K; Klopstock T
    Neurology; 2006 Oct; 67(7):1262-4. PubMed ID: 17030762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease.
    Evans AH; Lawrence AD; Potts J; MacGregor L; Katzenschlager R; Shaw K; Zijlmans J; Lees AJ
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):317-21. PubMed ID: 16484638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the relationship between caffeine intake and essential tremor.
    Prakash KM; Fook-Choong S; Yuen Y; Tan EK
    J Neurol Sci; 2006 Dec; 251(1-2):98-101. PubMed ID: 17049563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.
    Bega D; Kim S; Zhang Y; Elm J; Schneider J; Hauser R; Fraser A; Simuni T
    J Parkinsons Dis; 2015; 5(4):773-82. PubMed ID: 26639661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study.
    Altman RD; Lang AE; Postuma RB
    Mov Disord; 2011 Nov; 26(13):2427-31. PubMed ID: 21953603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking.
    Larsson SC; Giovannucci E; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):740-3. PubMed ID: 15767361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.
    Parkinson Study Group
    Arch Neurol; 2004 Apr; 61(4):561-6. PubMed ID: 15096406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.
    Ohmichi T; Kasai T; Kosaka T; Shikata K; Tatebe H; Ishii R; Shinomoto M; Mizuno T; Tokuda T
    PLoS One; 2018; 13(7):e0201260. PubMed ID: 30044870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of caffeine on microsurgical technical performance.
    Urso-Baiarda F; Shurey S; Grobbelaar AO
    Microsurgery; 2007; 27(2):84-7. PubMed ID: 17290375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine and creatine use in sport.
    Tarnopolsky MA
    Ann Nutr Metab; 2010; 57 Suppl 2():1-8. PubMed ID: 21346331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey.
    Choi HK; Curhan G
    Arthritis Rheum; 2007 Jun; 57(5):816-21. PubMed ID: 17530681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.